Setting

Global Onychomycosis Treatment Market 2021-2031 by Onychomycosis Type (Distal Subungual, White Superficial, Proximal Subungual, Candidal, Others), Treatment Type (Drug Treatment, Laser Therapy, Photodynamic Therapy, Others), Distribution Channel (Hospitals and Clinics, Online Stores, Retail Pharmacies, Others), and Region: Trend Forecast and Growth Opportunity

Published: 30 Apr 2022 | Report Code: 10248471 | Pages: 150

Global Onychomycosis Treatment Market will reach $5,787.4 million by 2031, growing by 7.9% annually over 2021-2031, driven by the increasing prevalence of chronic medical ailments, the growing geriatric population, improved therapies and preventative solutions, and the rising healthcare expenditure. Highlighted with 80 tables and 72 figures, this 150-page report “Global Onychomycosis Treatment Market 2021-2031 by Onychomycosis Type (Distal Subungual, White Superficial, Proximal Subungual, Candidal, Others), Treatment Type (Drug Treatment, Laser Therapy, Photodynamic Therapy, Others), Distribution Channel (Hospitals and Clinics, Online Stores, Retail Pharmacies, Others), and Region: Trend Forecast and Growth Opportunity” is based on comprehensive research of the entire global onychomycosis treatment market and all its sub-segments through extensively detailed classifications.

 

Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

 

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure

• Growth Drivers

• Restraints and Challenges

• Emerging Product Trends & Market Opportunities

• Porter’s Five Forces

 

The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and the Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify global onychomycosis treatment market in every aspect of the classification from perspectives of Onychomycosis Type, Treatment Type, Distribution Channel, and Region.

 

Based on Onychomycosis Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Distal Subungual Onychomycosis

• White Superficial Onychomycosis

• Proximal Subungual Onychomycosis

• Candidal Onychomycosis

• Other Onychomycosis Types

 

Based on Treatment Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Drug Treatment

• Laser Therapy

• Photodynamic Therapy

• Other Therapies

 

By Distribution Channel, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Hospitals and Clinics

• Online Stores

• Retail Pharmacies

• Other Distribution Channels

 

Geographically, the following regions together with the listed national/local markets are fully investigated:

• North America (U.S., Canada, and Mexico)

• Europe (Germany, UK, France, Spain, Italy, Netherlands, Rest of Europe; Rest of Europe is further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)

• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)

• South America (Brazil, Chile, Argentina, Rest of South America)

• MEA (UAE, Saudi Arabia, South Africa, Other Nations)

For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by Onychomycosis Type, Treatment Type and Distribution Channel over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

 

Selected Key Players:

Bausch Health Companies Inc.

Bayer AG

Cipla Ltd

Dr. Reddys Laboratories Ltd

Galderma SA

GlaxoSmithKline PLC

Johnson & Johnson

Lumenis Ltd

Medimetriks Pharmaceuticals Inc.

Moberg Pharma AB

Novartis AG

Pfizer Inc.

Sanofi SA

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table Of Contents:

1 Introduction    9
1.1 Industry Definition and Research Scope    9
1.1.1 Industry Definition    9
1.1.2 Research Scope    10
1.2 Research Methodology    13
1.2.1 Overview of Market Research Methodology    13
1.2.2 Market Assumption    14
1.2.3 Secondary Data    14
1.2.4 Primary Data    14
1.2.5 Data Filtration and Model Design    15
1.2.6 Market Size/Share Estimation    16
1.2.7 Research Limitations    17
1.3 Executive Summary    18
2 Market Overview and Dynamics    20
2.1 Market Size and Forecast    20
2.1.1 Impact of COVID-19 on World Economy    21
2.1.2 Impact of COVID-19 on the Market    23
2.2 Major Growth Drivers    25
2.3 Market Restraints and Challenges    32
2.4 Emerging Opportunities and Market Trends    35
2.5 Porter’s Fiver Forces Analysis    39
3 Segmentation of Global Market by Onychomycosis Type    43
3.1 Market Overview by Onychomycosis Type    43
3.2 Distal Subungual Onychomycosis    45
3.3 White Superficial Onychomycosis    46
3.4 Proximal Subungual Onychomycosis    47
3.5 Candidal Onychomycosis    48
3.6 Other Onychomycosis Types    49
4 Segmentation of Global Market by Treatment Type    50
4.1 Market Overview by Treatment Type    50
4.2 Drug Treatment    52
4.3 Laser Therapy    53
4.4 Photodynamic Therapy    54
4.5 Other Therapies    55
5 Segmentation of Global Market by Distribution Channel    56
5.1 Market Overview by Distribution Channel    56
5.2 Hospitals and Clinics    58
5.3 Online Stores    59
5.4 Retail Pharmacies    60
5.5 Other Distribution Channels    61
6 Segmentation of Global Market by Region    62
6.1 Geographic Market Overview 2021-2031    62
6.2 North America Market 2021-2031 by Country    66
6.2.1 Overview of North America Market    66
6.2.2 U.S.    70
6.2.3 Canada    73
6.2.4 Mexico    75
6.3 European Market 2021-2031 by Country    77
6.3.1 Overview of European Market    77
6.3.2 Germany    81
6.3.3 U.K.    83
6.3.4 France    85
6.3.5 Spain    87
6.3.6 Italy    89
6.3.7 Netherlands    91
6.3.8 Rest of European Market    93
6.4 Asia-Pacific Market 2021-2031 by Country    95
6.4.1 Overview of Asia-Pacific Market    95
6.4.2 Japan    99
6.4.3 China    102
6.4.4 Australia    104
6.4.5 India    106
6.4.6 South Korea    108
6.4.7 Rest of APAC Region    110
6.5 South America Market 2021-2031 by Country    112
6.5.1 Argentina    115
6.5.2 Brazil    117
6.5.3 Chile    119
6.5.4 Rest of South America Market    121
6.6 MEA Market 2021-2031 by Country    122
6.6.1 UAE    125
6.6.2 Saudi Arabia    127
6.6.3 South Africa    129
6.6.4 Other National Markets    131
7 Competitive Landscape    132
7.1 Overview of Key Vendors    132
7.2 New Product Launch, Partnership, Investment, and M&A    135
7.3 Company Profiles    136
Bausch Health Companies Inc.    136
Bayer AG    138
Cipla Ltd    139
Dr. Reddys Laboratories Ltd    140
Galderma SA    141
GlaxoSmithKline PLC    142
Johnson & Johnson    143
Lumenis Ltd    144
Medimetriks Pharmaceuticals Inc.    145
Moberg Pharma AB    146
Novartis AG    147
Pfizer Inc.    148
Sanofi SA    149
RELATED REPORTS    150

 

List Of Tables:

Table 1. Snapshot of Global Onychomycosis Treatment Market in Balanced Perspective, 2021-2031    19
Table 2. World Economic Outlook, 2021-2031    22
Table 3. Clinical Trials of Onychomycosis Treatment    28
Table 4. World Health Spending by Region, $ bn, 2013-2020    31
Table 5. Main Product Trends and Market Opportunities in Global Onychomycosis Treatment Market    35
Table 6. Global Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn    43
Table 7. Global Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn    50
Table 8. Global Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn    56
Table 9. Global Onychomycosis Treatment Market by Region, 2021-2031, $ mn    63
Table 10. Leading National Onychomycosis Treatment Market, 2021 and 2031, $ mn    65
Table 11. North America Onychomycosis Treatment Market by Country, 2021-2031, $ mn    68
Table 12. U.S. Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn    72
Table 13. U.S. Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn    72
Table 14. U.S. Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn    72
Table 15. Canada Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn    74
Table 16. Canada Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn    74
Table 17. Canada Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn    74
Table 18. Mexico Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn    76
Table 19. Mexico Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn    76
Table 20. Mexico Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn    76
Table 21. Europe Onychomycosis Treatment Market by Country, 2021-2031, $ mn    80
Table 22. Germany Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn    82
Table 23. Germany Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn    82
Table 24. Germany Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn    82
Table 25. U.K. Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn    84
Table 26. U.K. Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn    84
Table 27. U.K. Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn    84
Table 28. France Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn    86
Table 29. France Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn    86
Table 30. France Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn    86
Table 31. Spain Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn    88
Table 32. Spain Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn    88
Table 33. Spain Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn    88
Table 34. Italy Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn    90
Table 35. Italy Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn    90
Table 36. Italy Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn    90
Table 37. Netherlands Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn    92
Table 38. Netherlands Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn    92
Table 39. Netherlands Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn    92
Table 40. Onychomycosis Treatment Market in Rest of Europe by Country, 2021-2031, $ mn    94
Table 41. APAC Onychomycosis Treatment Market by Country, 2021-2031, $ mn    97
Table 42. Japan Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn    101
Table 43. Japan Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn    101
Table 44. Japan Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn    101
Table 45. China Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn    103
Table 46. China Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn    103
Table 47. China Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn    103
Table 48. Australia Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn    105
Table 49. Australia Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn    105
Table 50. Australia Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn    105
Table 51. India Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn    107
Table 52. India Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn    107
Table 53. India Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn    107
Table 54. South Korea Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn    109
Table 55. South Korea Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn    109
Table 56. South Korea Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn    109
Table 57. Onychomycosis Treatment Market in Rest of APAC by Country/Region, 2021-2031, $ mn    111
Table 58. South America Onychomycosis Treatment Market by Country, 2021-2031, $ mn    114
Table 59. Argentina Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn    116
Table 60. Argentina Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn    116
Table 61. Argentina Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn    116
Table 62. Brazil Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn    118
Table 63. Brazil Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn    118
Table 64. Brazil Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn    118
Table 65. Chile Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn    120
Table 66. Chile Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn    120
Table 67. Chile Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn    120
Table 68. MEA Onychomycosis Treatment Market by Country, 2021-2031, $ mn    124
Table 69. UAE Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn    126
Table 70. UAE Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn    126
Table 71. UAE Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn    126
Table 72. Saudi Arabia Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn    128
Table 73. Saudi Arabia Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn    128
Table 74. Saudi Arabia Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn    128
Table 75. South Africa Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn    130
Table 76. South Africa Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn    130
Table 77. South Africa Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn    130
Table 78. Bausch Health Companies Inc.: Company Snapshot    136
Table 79. Bausch Health Companies Inc.: Business Segmentation    137
Table 80. Bausch Health Companies Inc.: Product Portfolio    137

 

List Of Figures:

Figure 1. Research Method Flow Chart    13
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation    16
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031    18
Figure 4. Global Onychomycosis Treatment Market, 2021-2031, $ mn    20
Figure 5. Impact of COVID-19 on Business    23
Figure 6. Primary Drivers and Impact Factors of Global Onychomycosis Treatment Market    25
Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million    29
Figure 8. World Population 65 and Over, % of Total Population, 1950-2060    30
Figure 9. Primary Restraints and Impact Factors of Global Onychomycosis Treatment Market    32
Figure 10. Investment Opportunity Analysis    36
Figure 11. Porter’s Fiver Forces Analysis of Global Onychomycosis Treatment Market    39
Figure 12. Breakdown of Global Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, % of Revenue    44
Figure 13. Global Addressable Market Cap in 2022-2031 by Onychomycosis Type, Value ($ mn) and Share (%)    44
Figure 14. Global Onychomycosis Treatment Market by Onychomycosis Type: Distal Subungual Onychomycosis, 2021-2031, $ mn    45
Figure 15. Global Onychomycosis Treatment Market by Onychomycosis Type: White Superficial Onychomycosis, 2021-2031, $ mn    46
Figure 16. Global Onychomycosis Treatment Market by Onychomycosis Type: Proximal Subungual Onychomycosis, 2021-2031, $ mn    47
Figure 17. Global Onychomycosis Treatment Market by Onychomycosis Type: Candidal Onychomycosis, 2021-2031, $ mn    48
Figure 18. Global Onychomycosis Treatment Market by Onychomycosis Type: Other Onychomycosis Types, 2021-2031, $ mn    49
Figure 19. Breakdown of Global Onychomycosis Treatment Market by Treatment Type, 2021-2031, % of Sales Revenue    51
Figure 20. Global Addressable Market Cap in 2022-2031 by Treatment Type, Value ($ mn) and Share (%)    51
Figure 21. Global Onychomycosis Treatment Market by Treatment Type: Drug Treatment, 2021-2031, $ mn    52
Figure 22. Global Onychomycosis Treatment Market by Treatment Type: Laser Therapy, 2021-2031, $ mn    53
Figure 23. Global Onychomycosis Treatment Market by Treatment Type: Photodynamic Therapy, 2021-2031, $ mn    54
Figure 24. Global Onychomycosis Treatment Market by Treatment Type: Other Therapies, 2021-2031, $ mn    55
Figure 25. Breakdown of Global Onychomycosis Treatment Market by Distribution Channel, 2021-2031, % of Sales Revenue    57
Figure 26. Global Addressable Market Cap in 2022-2031 by Distribution Channel, Value ($ mn) and Share (%)    57
Figure 27. Global Onychomycosis Treatment Market by Distribution Channel: Hospitals and Clinics, 2021-2031, $ mn    58
Figure 28. Global Onychomycosis Treatment Market by Distribution Channel: Online Stores, 2021-2031, $ mn    59
Figure 29. Global Onychomycosis Treatment Market by Distribution Channel: Retail Pharmacies, 2021-2031, $ mn    60
Figure 30. Global Onychomycosis Treatment Market by Distribution Channel: Other Distribution Channels, 2021-2031, $ mn    61
Figure 31. Global Market Snapshot by Region    62
Figure 32. Geographic Spread of Worldwide Onychomycosis Treatment Market, 2021-2031, % of Sales Revenue    63
Figure 33. Global Addressable Market Cap in 2022-2031 by Region, Value ($ mn) and Share (%)    64
Figure 34. North American Onychomycosis Treatment Market, 2021-2031, $ mn    67
Figure 35. Breakdown of North America Onychomycosis Treatment Market by Country, 2021 and 2031, % of Revenue    68
Figure 36. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)    69
Figure 37. U.S. Onychomycosis Treatment Market, 2021-2031, $ mn    71
Figure 38. Canada Onychomycosis Treatment Market, 2021-2031, $ mn    73
Figure 39. Onychomycosis Treatment Market in Mexico, 2021-2031, $ mn    75
Figure 40. European Onychomycosis Treatment Market, 2021-2031, $ mn    78
Figure 41. Breakdown of European Onychomycosis Treatment Market by Country, 2021 and 2031, % of Revenue    79
Figure 42. Contribution to Europe 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)    80
Figure 43. Onychomycosis Treatment Market in Germany, 2021-2031, $ mn    81
Figure 44. Onychomycosis Treatment Market in U.K., 2021-2031, $ mn    83
Figure 45. Onychomycosis Treatment Market in France, 2021-2031, $ mn    85
Figure 46. Onychomycosis Treatment Market in Spain, 2021-2031, $ mn    87
Figure 47. Onychomycosis Treatment Market in Italy, 2021-2031, $ mn    89
Figure 48. Onychomycosis Treatment Market in Netherlands, 2021-2031, $ mn    91
Figure 49. Onychomycosis Treatment Market in Rest of Europe, 2021-2031, $ mn    93
Figure 50. Asia-Pacific Onychomycosis Treatment Market, 2021-2031, $ mn    96
Figure 51. Breakdown of APAC Onychomycosis Treatment Market by Country, 2021 and 2031, % of Revenue    96
Figure 52. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)    98
Figure 53. Onychomycosis Treatment Market in Japan, 2021-2031, $ mn    100
Figure 54. Onychomycosis Treatment Market in China, 2021-2031, $ mn    102
Figure 55. Onychomycosis Treatment Market in Australia, 2021-2031, $ mn    104
Figure 56. Onychomycosis Treatment Market in India, 2021-2031, $ mn    106
Figure 57. Onychomycosis Treatment Market in South Korea, 2021-2031, $ mn    108
Figure 58. Onychomycosis Treatment Market in Rest of APAC, 2021-2031, $ mn    110
Figure 59. South America Onychomycosis Treatment Market, 2021-2031, $ mn    113
Figure 60. Breakdown of South America Onychomycosis Treatment Market by Country, 2021 and 2031, % of Revenue    113
Figure 61. Contribution to South America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)    114
Figure 62. Onychomycosis Treatment Market in Argentina, 2021-2031, $ mn    115
Figure 63. Onychomycosis Treatment Market in Brazil, 2021-2031, $ mn    117
Figure 64. Onychomycosis Treatment Market in Chile, 2021-2031, $ mn    119
Figure 65. Onychomycosis Treatment Market in Rest of South America, 2021-2031, $ mn    121
Figure 66. Onychomycosis Treatment Market in Middle East and Africa (MEA), 2021-2031, $ mn    123
Figure 67. Breakdown of MEA Onychomycosis Treatment Market by Country, 2021 and 2031, % of Revenue    123
Figure 68. Contribution to MEA 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)    124
Figure 69. Onychomycosis Treatment Market in UAE, 2021-2031, $ mn    125
Figure 70. Onychomycosis Treatment Market in Saudi Arabia, 2021-2031, $ mn    127
Figure 71. Onychomycosis Treatment Market in South Africa, 2021-2031, $ mn    129
Figure 72. Growth Stage of Global Onychomycosis Treatment Industry over the Forecast Period    132
Selected Key Players: 

Bausch Health Companies Inc.
Bayer AG
Cipla Ltd
Dr. Reddys Laboratories Ltd
Galderma SA
GlaxoSmithKline PLC
Johnson & Johnson
Lumenis Ltd
Medimetriks Pharmaceuticals Inc.
Moberg Pharma AB
Novartis AG
Pfizer Inc.
Sanofi SA 
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)